Cartesian Therapeutics, Inc. (RNAC)
(Delayed Data from NSDQ)
$13.96 USD
-0.95 (-6.37%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $13.95 -0.01 (-0.07%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.78 |
EPS Last Quarter | 0.54 |
Last EPS Surprise | 166.67% |
ABR | 1.43 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.54 |
Next Year | -3.49 |
EPS (TTM) | -6.23 |
P/E (F1) | 3.50 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.00M | 6.00M | 43.29M | 24.00M |
# of Estimates | 1 | 1 | 3 | 1 |
High Estimate | 6.00M | 6.00M | 51.29M | 24.00M |
Low Estimate | 6.00M | 6.00M | 39.29M | 24.00M |
Year ago Sales | 6.55M | 8.27M | 26.00M | 43.29M |
Year over Year Growth Est. | -8.40% | -27.45% | 66.49% | -44.56% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.78 | -0.73 | -4.54 | -3.49 |
# of Estimates | 4 | 3 | 2 | 4 |
Most Recent Consensus | -0.94 | -0.82 | -5.03 | -3.73 |
High Estimate | -0.55 | -0.57 | -4.05 | -2.30 |
Low Estimate | -0.97 | -0.89 | -5.03 | -4.30 |
Year ago EPS | -2.40 | -2.40 | -10.21 | -4.54 |
Year over Year Growth Est. | 67.50% | 69.58% | 55.53% | 23.13% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 2 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 0 | 2 |
Down Last 60 Days | 2 | 2 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.78 | -0.73 | -4.54 | -3.49 |
7 Days Ago | -0.78 | -0.73 | -4.54 | -3.49 |
30 Days Ago | -0.68 | -0.64 | -5.92 | -2.89 |
60 Days Ago | -0.72 | -0.70 | -5.92 | -3.23 |
90 Days Ago | -0.80 | -0.77 | -6.73 | -3.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.78 | -0.73 | -4.54 | -3.49 |
Zacks Consensus Estimate | -0.78 | -0.73 | -4.54 | -3.49 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.54 | -1.97 | -2.40 | -2.40 | NA |
Estimate | -0.81 | -0.81 | -0.30 | -2.10 | NA |
Difference | 1.35 | -1.16 | -2.10 | -0.30 | -0.55 |
Surprise | 166.67% | -143.21% | -700.00% | -14.29% | -172.71% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more